FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
Back to search
Official data from USPTO
GCSA GLOBAL CLINICAL SITE ACCREDITATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Quick snapshot
ST13
US500000079371028Class
35, 41, 42, 45
Filing
79371028
Registration
7416560
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
35, 41, 42, 45
Filing date
01/06/2023
Registration date
06/18/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/18/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
CHOSID, ROBIN S
Law office
L20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of four concentric curved lines in gradations of blue-green to the left of the wording "GCSA" | "GLOBAL CLINICAL SITE ACCREDITATION" in black. There is a black vertical line between the abbreviation and the wording.
Holders and representatives
Holders
Global Clinical Site Assessment Limited
Representatives
Bradley M. Stohry Reichel Stohry Dean LLP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Provision of business advice and assistance in the field of clinical trial site competencypractices and processes; gap analysis and process improvementbusiness advice and management servicesin the field of clinical trial site competencypractices and processes; human resource advice and management services in the field of clinical trial site competencypractices and processes; human resource process improvement services in the field of clinical trial site competencypractices and processes; informationadvisory and consultancy services in relation to all of the aforementioned services
Class 41
Organisation of educational conferencesexhibitions and seminars for best practice sharing in the field of clinical trial site competencypractices and processes; informationadvisory and consultancy services in relation all of the aforementioned services
Class 42
Quality evaluationcheckingauditing and assurance services in the field of clinical research site competencypractices and processes to determine conformity with certification standards; quality checking in the field of clinical trial site competencypractices and processes; quality auditing in the field of clinical trial site competencypractices and processes; quality evaluation of clinical research sites to determine conformity with established accreditation standards; quality evaluation of clinical research sites to determine whether the organizations conform to an established accreditation standard of competencypractices and processes; clinical research and clinical trials quality evaluation services to determine conformity with established accreditation standards; informationadvisory and consultancy services in relation to all the aforementioned services
Class 45
Reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trial site competencypractices and processes; review and preparation of regulationsstandards and compliance procedures being legal services in the field of clinical trial site competencypractices and processes; informationadvisory and consultancy services in relation to all of the aforementioned services
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/06/2024
FIMP
FINAL DISPOSITION PROCESSED
12/06/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/18/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2024
PUBO
PUBLISHED FOR OPPOSITION
04/02/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2024
RFNT
REFUSAL PROCESSED BY IB
11/22/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/30/2023
RFRR
REFUSAL PROCESSED BY MPU
10/30/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2023
CNRT
NON-FINAL ACTION WRITTEN
10/26/2023
DOCK
ASSIGNED TO EXAMINER
09/29/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2023
Continuous trademark protection
Get notified about every new filing that threatens GCSA GLOBAL CLINICAL SITE ACCREDITATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.